Northwest Biotherapeutics, Inc. (OTCMKTS:NWBO – Get Free Report)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.29 and traded as low as $0.25. Northwest Biotherapeutics shares last traded at $0.25, with a volume of 5,114,851 shares changing hands.
Northwest Biotherapeutics Stock Down 3.8 %
The firm has a market capitalization of $340.82 million, a PE ratio of -3.13 and a beta of -0.51. The stock has a 50-day moving average price of $0.27 and a 200 day moving average price of $0.29.
Northwest Biotherapeutics Company Profile
Northwest Biotherapeutics, Inc, a biotechnology company, develops personalized immune therapies for cancer in the United States and internationally. The company develops its products based on DCVax, a platform technology that uses activated dendritic cells to mobilize a patient’s own immune system to attack cancer.
Recommended Stories
- Five stocks we like better than Northwest Biotherapeutics
- What is a buyback in stocks? A comprehensive guide for investors
- Corporate Crawl: Where Business Trips Turn Into Party Nights
- What Are Dividend Challengers?
- CrowdStrike’s Growth Remains Strong—Buy While It’s Down
- How Technical Indicators Can Help You Find Oversold Stocks
- Is Advanced Micro Devices Stock Slide Over?
Receive News & Ratings for Northwest Biotherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Northwest Biotherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
